Abstract
Pleiotrophin (PTN), an angiogenic factor, is associated with various types of cancer, including lung cancer. Our aim was to investigate the possibility of using serum PTN as an early indicator regarding disease diagnosis, classification and prognosis, for patients with non-small cell lung cancer (NSCLC). Significant differences among PTN levels in patients with small cell lung cancer (SCLC, n=40), NSCLC (n=136), and control subjects with benign pulmonary lesions (n=21), as well as patients with different pathological subtypes of NSCLC were observed. A serum level of PTN of 300.1 ng/ml, was determined as the cutoff value differentiating lung cancer patients and controls, with a sensitivity and specificity of 78.4% and 66.7%, respectively. Negative correlations between serum PTN level and pathological differentiation level, stage, and survival time were observed in our cohort of patients with NSCLC. In addition, specific elevation of PTN levels in pulmonary tissue in and around NSCLC lesions in comparison to normal pulmonary tissue obtained from the same subjects was also observed (n=2). This study suggests that the serum PTN level of patients with NSCLC could be an early indicator for diagnosis and prognosis. This conclusion sho...Continue Reading
References
Jan 1, 1992·Molecular Biology of the Cell·B S HamptonW H Burgess
Oct 30, 1990·Biochemical and Biophysical Research Communications·I KovesdiP Böhlen
Apr 30, 1991·Biochemical and Biophysical Research Communications·J TsutsuiT Muramatsu
Dec 29, 1989·Biochemical and Biophysical Research Communications·P G MilnerT F Deuel
Jan 1, 1995·Progress in Growth Factor Research·K LaaroubiJ Courty
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·A M SchulteA Wellstein
Dec 6, 1997·International Journal of Cancer. Journal International Du Cancer·R JägerG Zugmaier
Oct 17, 1998·Journal of the National Cancer Institute·B SouttouA Wellstein
Apr 16, 2002·British Journal of Cancer·R JägerG Zugmaier
Jul 15, 2003·Respirology : Official Journal of the Asian Pacific Society of Respirology·Hong Zhang, Baiqiang Cai
Mar 12, 2004·Cancer Letters·Kenji Kadomatsu, Takashi Muramatsu
May 24, 2005·The Journal of Biological Chemistry·Kan V LuPaul S Mischel
Oct 13, 2005·Development Genes and Evolution·Camilla EnglundRuth H Palmer
Jul 15, 2006·Human Gene Therapy·Marius GrzelinskiAchim Aigner
Feb 20, 2010·European Cytokine Network·Evangelia PapadimitriouPanagiotis Boudouris
Nov 7, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Zhu-Qing JiJin-Hai Tang
Citations
Feb 18, 2016·Disease Markers·Mingzhong SunHuixiang Ju
Oct 25, 2016·Biochimica Et Biophysica Acta·Evangelia PapadimitriouDimitris Beis
Jun 1, 2017·PloS One·Lisha ZhaYaou Zhang
Jun 2, 2017·Nature Communications·Yu ShiXiu-Wu Bian
Jan 13, 2019·Journal of Cellular and Molecular Medicine·Chunhua XuXiuwei Zhang
May 1, 2017·Oncotarget·Liping DaiJianying Zhang
Oct 4, 2017·Oncotarget·Dapeng WuDaliu Min
Dec 30, 2017·International Journal of Molecular Medicine·Rui WangZhengxia Wu
Nov 9, 2017·Molecular Medicine Reports·Lei LiuQin Zhang
Sep 28, 2017·Cancer Biomarkers : Section a of Disease Markers·Nicole M GiamancoJeffrey Baron
Apr 12, 2019·Interdisciplinary Sciences, Computational Life Sciences·Anil Kumar TomarBishwajit Kundu
Oct 9, 2021·Drug Discovery Today·Sepideh MirzaeiGorka Orive